BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 2481671)

  • 1. The use of chemotherapy in metastatic breast cancer.
    Garber JE; Henderson IC
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):807-21. PubMed ID: 2481671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for managing metastatic breast cancer.
    Olin JJ; Muss HB
    Oncology (Williston Park); 2000 May; 14(5):629-41; discussion 642-4, 647-8. PubMed ID: 10853456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life as a treatment endpoint in metastatic breast cancer.
    Osoba D
    Can J Oncol; 1995 Dec; 5 Suppl 1():47-53. PubMed ID: 8853525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic breast cancer: understanding current management options.
    McGinn K; Moore J
    Oncol Nurs Forum; 2001 Apr; 28(3):507-12; quiz 513-4. PubMed ID: 11338758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary chemotherapy in operable breast carcinoma].
    Bonadonna G; Valagussa P
    Ann Ital Chir; 1999; 70(3):359-69. PubMed ID: 10466239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of anthracycline-resistant metastatic breast carcinoma].
    Kreienberg R
    Praxis (Bern 1994); 1998 Apr; 87(17):573-7. PubMed ID: 9623323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has first-line therapy had an impact on general outcome in metastatic breast cancer?
    McArthur HL; Hudis CA
    Future Oncol; 2007 Aug; 3(4):411-8. PubMed ID: 17661716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
    Henderson IC
    Important Adv Oncol; 1990; ():199-216. PubMed ID: 1691137
    [No Abstract]   [Full Text] [Related]  

  • 10. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of metastatic breast cancer].
    Eidtmann H; Jonat W
    Ther Umsch; 1993 May; 50(5):352-8. PubMed ID: 7690992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance treatment in metastatic breast cancer.
    Sánchez-Muñoz A; Pérez-Ruiz E; Ribelles N; Márquez A; Alba E
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1907-12. PubMed ID: 19046111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
    Halterman PA
    Pharmacotherapy; 2008 Oct; 28(10):1255-66. PubMed ID: 18823221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Köstler WJ; Brodowicz T; Zielinski CC;
    J Natl Cancer Inst; 2010 Feb; 102(3):207; author reply 207-8. PubMed ID: 20054016
    [No Abstract]   [Full Text] [Related]  

  • 15. Principles of therapy in advanced breast cancer.
    Ingle JN
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):743-63. PubMed ID: 2481669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin in combination therapy for metastatic breast cancer.
    Perez EA
    Oncologist; 2004; 9(5):518-27. PubMed ID: 15477636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic palliative approaches in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):2-9. PubMed ID: 7537899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of endocrine therapy.
    Pritchard KI; Sutherland DJ
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):765-805. PubMed ID: 2481670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.